The publisher's Medical Devices sector report, “Artificial Lung - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Artificial Lung pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Artificial Lung is a prosthetic device works as an alternative to the biological lung. It provides oxygenation of blood and removal of carbon dioxide from the blood.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to -
Artificial Lung is a prosthetic device works as an alternative to the biological lung. It provides oxygenation of blood and removal of carbon dioxide from the blood.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Artificial Lung under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Lung and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Lung under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Artificial Lung - Pipeline Products under Development by Companies
5 Artificial Lung Companies and Product Overview
6 Artificial Lung- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ALung Technologies Inc
- Belluscura Limited
- Breethe, Inc.
- Case Western Reserve University
- enmodes GmbH
- Lung Biotechnology PBC
- MC3 Inc
- McGowan Institute for Regenerative Medicine
- Miromatrix Medical Inc
- The Charles Stark Draper Laboratory Inc
- U.S. Ann Arbor Healthcare System
- University of Pittsburgh
- Veterans Health Administration
